The alternative cap-binding complex is required for antiviral defense in vivo

March 10, 2020 10:07 am Published by

Gebhardt, A., V. Bergant, D. Schnepf, M. Moser, A. Meiler, D. Togbe, C. Mackowiak, L. S. Reinert, S. R. Paludan, B. Ryffel, A. Stukalov, P. Staeheli, and A. Pichlmair. 2019. The alternative cap-binding complex is required for antiviral defense in vivo. PLoS Pathog 15: e1008155.

Categorised in:

This post was written by Heike Ufheil